Drug information for APTIVUS
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
250MG
Prescription
(Reference Drug)
TIPRANAVIR
tipranavir
BOEHRINGER INGELHEIM
21814
2012-02-27 Letter
2012-02-22 Label
2011-04-07 Letter
2011-04-06 Label
2010-09-07 Letter
2010-08-16 Label
2010-05-12 Summary Review
2010-05-12 Review
2010-05-07 Label
2010-05-03 Letter
2009-06-24 Label
2009-06-24 Letter
2008-06-26 Letter
2008-06-26 Label
2007-10-10 Label
2007-10-10 Letter
2007-05-29 Letter
2006-08-18 Letter
2006-08-18 Letter
2006-08-14 Label
2006-08-14 Label
2005-09-02 Review
2005-06-24 Letter
2005-06-23 Label
SOLUTION; ORAL
100MG/ML
Prescription
(Reference Drug)
TIPRANAVIR
tipranavir
BOEHRINGER INGELHEIM
21822
2010-04-21 Review
2010-04-21 Summary Review
2008-06-26 Label
2008-06-26 Letter
SOLUTION; ORAL
100MG/ML
Prescription
(Reference Drug)
TIPRANAVIR
tipranavir
BOEHRINGER INGELHEIM
22292
2012-02-27 Letter
2012-02-22 Label
2011-04-07 Letter
2011-04-06 Label
2010-09-07 Letter
2010-08-16 Label
2010-05-12 Review
2010-05-12 Summary Review
2010-05-07 Label
2010-05-03 Letter
2009-06-24 Letter
2009-06-24 Label
2008-06-26 Label
2008-06-26 Letter
Drug Adverse Effects information for APTIVUS
Role code
Indications
Reaction
# Reports
C
HIV INFECTION
LUNG NEOPLASM MALIGNANT
9
C
PRODUCT USED FOR UNKNOWN INDICATION
LUNG NEOPLASM MALIGNANT
1
Ads by Google